An update on apocrine lesions of the breast
Authors:
- 13 December 2007
- journal article
- review article
- Published by Wiley in Histopathology
- Vol. 52 (1) , 3-10
Abstract
Apocrine change occurs in a spectrum of benign lesions in the female breast and is also demonstrated in a subgroup of in situ and invasive carcinomas. Recent research has focused on the molecular phenotype of both benign and malignant apocrine lesions. This review will briefly summarize the morphological characteristics and risk associations of the spectrum of apocrine proliferations, but will focus on the updated molecular studies of both in situ and invasive apocrine carcinomas.Keywords
This publication has 47 references indexed in Scilit:
- Apocrine Cysts of the BreastMolecular & Cellular Proteomics, 2006
- High-Resolution Chromosome 3p Allelotyping of Breast Carcinomas and Precursor Lesions Demonstrates Frequent Loss of Heterozygosity and a Discontinuous Pattern of Allele LossThe American Journal of Pathology, 2001
- Molecular Cytogenetic Comparison of Apocrine Hyperplasia and Apocrine Carcinoma of the BreastThe American Journal of Pathology, 2001
- Loss of Heterozygosity in Fibrocystic Change of the BreastThe American Journal of Pathology, 2000
- Risk of breast cancer in women with palpable breast cysts: a prospective studyThe Lancet, 1999
- Immunohistochemical Analysis of Apocrine Breast LesionsPathology - Research and Practice, 1997
- bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancerBritish Journal of Cancer, 1994
- Is there an increased risk of breast cancer in women who have had a breast cyst aspirated?British Journal of Cancer, 1991
- Risk of breast cancer in women with history of benign disease of the breast.BMJ, 1984
- The presentation and progress of macroscopic breast cystsBritish Journal of Surgery, 1980